Qube Research & Technologies LTD Morphic Holding, Inc. Transaction History

Qube Research & Technologies LTD

  • $62.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$26.01 - $48.69 $134,289 - $251,386
-5,163 Reduced 34.26%
9,909 $372,000
Q4 2022

Feb 14, 2023
BUY
$24.14 - $30.37 $363,838 - $457,736
15,072 New
15,072 $403,000
Q2 2022

Aug 15, 2022
BUY
$19.74 - $43.01 $802,549 - $1.75 Million
40,656 Added 814.59%
45,647 $991,000
Q1 2022

May 09, 2022
BUY
$36.25 - $52.02 $180,923 - $259,631
4,991 New
4,991 $200,000

Others Institutions Holding MORF

# of Institutions
140
Shares Held
38.7M
Call Options Held
4.2K
Put Options Held
200K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email